Sirot D, Chanal C, Labia R, Meyran M, Sirot J, Cluzel R
Service be Bactériologie, Faculté de Médecine, Clermont-Ferrand, France.
J Antimicrob Chemother. 1989 Oct;24(4):509-21. doi: 10.1093/jac/24.4.509.
Five plasmid-mediated beta-lactamases conferring a high level of resistance to ceftazidime were isolated from Klebsiella pneumoniae strains. These ceftazidimases (CAZ) differed in their isoelectric point (from 5.3 to 8.2) and were encoded by large self-transferable plasmids of 85 kb (CAZ-2, CAZ-3) or greater than or equal to 150 kb (CAZ-1, CAZ-4, CAZ-5). The 85 kb plasmids seemed closely related to pCFF04 encoding CTX-1 enzyme and belonged to the same incompatibility group 7 or M. These beta-lactamases hydrolysed all beta-lactams with the exception of cephamycins and carbapenems. For CAZ-1, CAZ-2 and CAZ-3 producers, MICs of ceftazidime (32-256 mg/l) were higher than MICs of cefotaxime (0.12-2 mg/l) and aztreonam (1-16 mg/l). For the strains producing the beta-lactamases CAZ-4 and CAZ-5, MICs of aztreonam were the highest (greater than or equal to 256 mg/l). The impaired activities of cephalosporins and monobactams were restored equally well by 2 mg/l of clavulanate, sulbactam and CL-298741 for CAZ-2 producing strains (wild type and transconjugant). Sulbactam (2 mg/l) had a lower protective effect than other inhibitors on ceftazidime for CAZ-1 and CAZ-3 producing K. pneumoniae. The protective effect of sulbactam (2 mg/l) was lower than that of the other inhibitors on all beta-lactams for CAZ-4 and CAZ-5 producers. The enzymes CAZ-1, CAZ-2 and CAZ-3 derived from TEM beta-lactamase whereas CAZ-4 and CAZ-5 derived from SHV-1 enzyme.
从肺炎克雷伯菌菌株中分离出了五种介导质粒的β-内酰胺酶,它们对头孢他啶具有高度抗性。这些头孢他啶酶(CAZ)的等电点不同(从5.3到8.2),由85 kb(CAZ-2、CAZ-3)或大于或等于150 kb(CAZ-1、CAZ-4、CAZ-5)的大型自我转移质粒编码。85 kb的质粒似乎与编码CTX-1酶的pCFF04密切相关,属于同一不相容群7或M。这些β-内酰胺酶能水解除头孢霉素和碳青霉烯类以外的所有β-内酰胺类抗生素。对于产生CAZ-1、CAZ-2和CAZ-3的菌株,头孢他啶的最低抑菌浓度(MIC)(32 - 256 mg/l)高于头孢噻肟(0.12 - 2 mg/l)和氨曲南(1 - 16 mg/l)的MIC。对于产生β-内酰胺酶CAZ-4和CAZ-5的菌株,氨曲南的MIC最高(大于或等于256 mg/l)。对于产生CAZ-2的菌株(野生型和转接合子),2 mg/l的克拉维酸、舒巴坦和CL-298741对头孢菌素和单环β-内酰胺类抗生素活性受损的恢复效果相同。对于产生CAZ-1和CAZ-3的肺炎克雷伯菌,舒巴坦(2 mg/l)对头孢他啶的保护作用低于其他抑制剂。对于产生CAZ-4和CAZ-5的菌株,舒巴坦(2 mg/l)对所有β-内酰胺类抗生素的保护作用低于其他抑制剂。酶CAZ-1、CAZ-2和CAZ-3源自TEMβ-内酰胺酶,而CAZ-4和CAZ-5源自SHV-1酶。